|
Apr 4
|
Time to Tap Healthcare ETFs on Nvidia's AI Ambition?
|
|
Apr 4
|
Big Pharma Stocks Need a Rethink. Investors Keep Making the Same Mistake.
|
|
Apr 3
|
Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report?
|
|
Apr 3
|
Johnson & Johnson CIO says employee upskilling is key to transforming health care
|
|
Apr 3
|
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
|
|
Apr 2
|
Johnson & Johnson (JNJ) Stock Moves -0.03%: What You Should Know
|
|
Apr 1
|
UPDATE 1-Teva, Viatris win new chance to challenge J&J schizophrenia drug patent
|
|
Apr 1
|
Teva, Viatris win new chance to challenge J&J schizophrenia drug patent
|
|
Mar 31
|
2024 S&P 500 Bull Market: 2 Unstoppable Growth Stocks to Buy Right Now
|
|
Mar 30
|
3 Reliable Dividend Growth Stocks With Yields Above 3% That You Can Buy Now and Hold for at Least a Decade
|
|
Mar 29
|
25 Things Every Dividend Investor Should Know
|
|
Mar 29
|
Here is What to Know Beyond Why Johnson & Johnson (JNJ) is a Trending Stock
|
|
Mar 29
|
Why Shockwave Medical Stock Rallied as Much as 18% Higher This Week
|
|
Mar 29
|
14 Best Stocks To Buy According to AI
|
|
Mar 29
|
Declining Stock and Decent Financials: Is The Market Wrong About Johnson & Johnson (NYSE:JNJ)?
|
|
Mar 28
|
3 Value Stocks to Buy on the Dip: March 2024
|
|
Mar 28
|
20 Best Stocks to Buy Right Now According to Financial Media
|
|
Mar 28
|
Shockwave Medical (SWAV) Up on Potential Acquisition Rumors
|
|
Mar 28
|
3 Dividend Stocks That Are Likely to Raise Their Payouts in April
|
|
Mar 27
|
UPDATE 2-J&J can contest evidence linking its talc to cancer, US judge rules
|